MarketWire -- London, UK; Brentwood, TN, US; 8 August 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that the
following notification of interest in the ordinary share capital of the
Company was received today from Aviva plc.
